Nonimmediate allergic reactions induced by drugs: Pathogenesis and diagnostic tests

Journal of Investigational Allergology and Clinical Immunology

Volumn 19, Issue 2, 2009, Pages 80-90

  Torres, M J ^a   Mayorga, C ^a   Blanca, M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Allergy; Diagnosis; Drugs; Nonimmediate; Pathogenesis; T cells

Indexed keywords

ALLOPURINOL; AMINOPENICILLIN; AMOXICILLIN; ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CEPHALOSPORIN DERIVATIVE; CHLORMEZANONE; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DIPYRONE; GAMMA INTERFERON; GRANZYME B; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; IODINATED CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PERFORIN; PHENOBARBITAL; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TETRACYCLINE; TETRAZEPAM; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIGEN EXPRESSION; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DESQUAMATION; DIFFERENTIAL DIAGNOSIS; DRESS SYNDROME; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EFFECTOR CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; INTRACUTANEOUS TEST; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; PATCH TEST; PATHOGENESIS; PROVOCATION TEST; PUSTULOSIS; REVIEW; SKIN TEST; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE ACTIVATION; TH1 CELL; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VIRUS INFECTION;

CELL TRANSFORMATION, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; SKIN TESTS; STEVENS-JOHNSON SYNDROME; T-LYMPHOCYTES; URTICARIA; VIRUS DISEASES;

EID: 65249130611     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. WHO. International drug monitoring: the role of national centres. Tech Rep Ser WHO, no 498. 1972.
2. Rawlins M, ThompsonW. Mechanisms of adverse drug reactions. In: Davies D, ed. Textbook of adverse drug reactions. New York: Oxford University Press, 1991;18-45.
3. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-16.
4. Coombs PR, Gell PG. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell RR, ed. Clinical aspects of immunology. Oxford: Oxford University Press, 1968;575-96.
5. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;39:683-93.
6. Levine BB. Immunologic mechanisms of penicillin allergy: a haptenic model system for the study of allergic diseases of man. N Engl J Med 1966;275:1 1 1 5-25.
7. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, Pichler WJ, Demoly P; ENDA; EAACI. Diagnosis of nonimmediate reactions to betalactams antibiotics. Allergy 2004;59:1 153-60.
8. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209:123-9.
9. Gielen K, Goosens A. Occupational allergic contact dermatitis from drug healthy healthcare workers. Contact Dermatitis 2001;45:273-9.
10. Kearns GL, Wheeler JG, Childress SH, Letzig LG. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatrics 1994; 125:805-1 1.
11. Wakelin S, Sidhu S, Orton DI, Chia Y, Shaw S. Amoxycillin induced flexural exanthema. Clinical Exp Dermatol 1999; 24:71-3.
12. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002;138:1019-24.
13. Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, Hollander N, Bruppacher R, Schópf E. Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens- Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990-1992). Structure and results of a population based registry. J Clin Epidemiol 1996; 49:769-73.
14. Torres MJ, Mayorga C, Fernandez TD, Cornejo-Garcia JA, Antunez C, Valenzuela M, Del Prado MF, Rodriguez-Pena R, Blanca M. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006;19:119-30.
15. Padial A, Posadas S, Alvarez J, Torres MJ, Alvarez JA, Mayorga C, Blanca M. Nonimmediate reactions to systemic corticosteroids suggest an immunological mechanism. Allergy 2005;60:665-70.
16. Torres MJ, Mayorga C, Cornejo-Garcia JA, Lopez S, Chaves P, Rondon C, Fernandez T, Blanca M. Monitoring non-immediate allergic reactions to iodine contrast media. Clin Exp Immunol 2008;1 52:233-8.
17. Roujeau J-C, Kelly JP, Naldi L, Rzany B, Stern S, Anderson T et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
18. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35-44.
19. Lutz MB, Schuler G. Immature, semimature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23:445-9.
20. Merk HF, Hertl M. Immunologic mechanisms of cutaneous drug reactions. Semin Cutan Med Surg 1996;1 5:228-35.
21. Leyva L, Torres MJ, Posadas S, Blanca M, Besso G, O'Valle F, del Moral RG, Santamaría LF, Juárez C. Anticonvulsant induced toxic epidermal necrolysis: Monitoring the immunological response. J Allergy Clin Immunol 2000;105:157-65.
22. Blanca M, Posadas S, Torres MJ, Leyva L, Mayorga C, Gonzalez L, Juarez C, Fernández J, Santamaria LF. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions. Allergy 2000;55:998-1004.
23. Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellon T. CCL27-CCR10 in drug-induced cutaneous reactions: Involvement in SJS and TEN. J Allergy Clin Immunol. 2004;1 14: 335-40.
24. Fernández TD, Mayorga C, Torres MJ, Cornejo-García JA, López S, Chaves P, Rondon C, Blanca M. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008;63: 712-9.
25. Posadas SJ, Leyva L, Torres MJ, Rodriguez JL, Bravo I, Rosal M, Fernández J, Juárez C, Blanca M. Subjects with allergic reactions to drugs show polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000;106:769-76.
26. Cornejo-García JA, Fernandez TD, Torres MJ, Carballo M, Hernan I, Antúnez C, Blanca M, Mayorga C. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007;62:1429-38.
27. Posadas S, Padial A., Torres MJ, Mayorga C, Leyva L, Sanchez E, Alvarez J, Romano A, Juarez C, Blanca M. Delayed reactions to drugs show a Th1 profile and levels of perforin, granzyme B and Fas-L related to disease severity. J Allergy Clin Immunol 2002;109:155-61.
28. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, Pichler WJ. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001;31:1398-408.
29. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000;30:847-55.
30. Naisbitt DJ. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 2004;94:179-96.
31. Villada G, Roujeau JC, Clérici T, Bourgault I, Revuz J. Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol 1992;128:50-3.
32. Roujeau JC, Dubertret L, Moritz S, Jouault H, Heslan M, Revuz J, Touraine R. Involvement of macrophages in the pathology of toxic epidermal necrolysis. Br J Dermatol. 1985;113:425-30.
33. Friedmann PS, Strickland I, Pirmohamed M, Park BK. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol. 1994;130:598-604.
34. Friedmann PS, Lee MS, FriedmannAC, Barnetson RS. Mechanisms in cutaneous drug hypersensitivity reactions. Clin Exp Allergy 2003;33:861-72.
35. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol. 2004;1 14:1209-15.
36. Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 2004;123:850-5.
37. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ. T-cell involvement in drug- induced acute generalized exanthematous pustulosis. J Clin Invest. 2001;107:1433-41.
38. Padial MA, Alvarez-Ferreira J, Tapia B, Blanco R, Mañas C, Blanca M, Bellón T. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br J Dermatol. 2004;150:139-42.
39. Yawalkar N. Drug-induced exanthems. Toxicology 2005; 209:131-4.
40. Ito K, Hara H, Okada T, Shimojima H, Suzuki H. Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression. Clin. Exp. Dermatol. 2004;29:679-80.
41. Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, Svensson CK. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J. Invest. Dermatol. 2000;114: 1164-73.
42. von Greyerz S, Zanni MP, Frutig K, Schnyder B, Burkhart C, Pichler WJ. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human T cell clones. J. Immunol. 1999;162: 595-602.
43. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.
44. Heath WR, Carbone FR. Immunology: dangerous liaisons. Nature 2003;425:460-1.
45. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-5.
46. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999;5:1249-55.
47. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001;2:947-50.
48. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-a, and contact sensitizers. J Immunol 2001;166:3837-45.
49. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1 in the initiation of primary immune responses in skin. J Immunol 1993;150:3698-704.
50. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A 1992;89:1398-402.
51. Boisleve F, Kerdine-Romer S, Rougier-Larzat N, Pallardy M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. J Invest Dermatol 2004;123:494-502.
52. Sanderson JP et al. Sanderson JP, Naisbitt DJ, Farrell J, Ashby CA, Tucker MJ, Rieder MJ, Pirmohamed M, Clarke SE, Park BK. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 2007;178:5533-42.
53. Rodríguez-Pena R, López S, Mayorga C, Antúnez C, Fernández TD, Torres MJ, Blanca M. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol. 2006;118:949-56.
54. López S, Blanca-López N, Cornejo-García JA, Canto G, Torres MJ, Mayorga C, Blanca M. Nonimmediate reactions to betalactams. Curr Opin Allergy Clin Immunol. 2007;7:310-6.
55. Merk HF, Niederau D, Hertl M, Jugert F. Drug metabolism and drug allergy. In: New Trends in Allergy III (Ring J, Braun-Falco O, eds). Heidelberg: Springer-Verlag, 1991.
56. Levy M. The combined effect of virus and drugs in drug-induced diseases. Med Hypotheses 1984; 14: 293-6; 11.
57. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr. Opin. Allergy Clin. Immunol. 2003;3:255-60.
58. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br. J. Dermatol. 2003;148: 1032-4.
59. Pirmohamed M, Park BK. HIV and drug allergy. Curr. Opin. Allergy Clin. Immunol. 2001;1: 311-6.
60. Shiohara T, Kano Y. A Complex Interaction Between Drug Allergy and Viral Infection. Clin Rev Allerg Immunol 2007;33:124-33.
61. Breathnach SM, Hintner H. Adverse Drug Reactions and the Skin. Oxford: Blackwell Scientific Publications, 1992.
62. Dakdouki GK, Obeid KH, Kanj SS. Azithromycin-induced rash in infectious mononucleosis. Scan J Infect Dis 2002;34:939-41.
63. González-Delgado P, Blanes M, Soriano V, Montoro D, Loeda C, Niveiro E. Erythema multiforme to amoxicillin with concurrent infection by Epstein-Barr virus. Allergol et Immunopathol 2006;34:76-8.
64. Renn CN, Straff W, Dorfmüller A, Al-Masaoudi T, Merk HF, Sachs B. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002;147:1166-70.
65. Peyriére H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D, Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side- effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155:422-8.
66. Tamagawa-Mineoka R, Katoh N, Nara T, Nishimura Y, Yamamoto S, Kishimoto S. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6. Int J Dermatol 2007;46:654-5.
67. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun- Vignes B, Belaich S, Crickx B. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol. 2001;137:301-4.
68. Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by realtime quantitative polymerase chain reaction. Br J Dermatol. 2003;149:165-9.
69. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004;140:183-8
70. Torres MJ, Corzo JL, Leyva L, Mayorga C, Garcia-Martin FJ, Antunez C, Posadas S, Jurado A, Blanca M. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Mol Dis 2003;30:124-31.
71. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005;152:968-74.
72. Romano A, Viola M, Mondino C, Pettinato R, Di Fonso M, Papa G, Venuti A, Montuschi P. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002;129:169-74.
73. Padial A, Antúnez C, Blanca-López N, Fernández TD, Cornejo-García JA, Mayorga C, Torres MJ, Blanca M. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008;38:822-8.
74. Blanca-López N, Zapatero L, Alonso E, Blanca M, Torres MJ, Fuentes V, Martínez-Molero MI. Role of skin testing and drug provocation tests in the diagnosis of non-immediate reactions to aminopenicillins in children. Allergy (in press).
75. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernández J, Brockow K, Pichler WJ, Demoly P; European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63.
76. Romano A, Di Fonso M, Papa G, Pietrantonio F, Federico F, Fabrizi G, Venuti A. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995;50:113-8.
77. Trcka J, Seitz CS, Brócker EB, Gross GE, Trautmann A. Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. J Antimicrob Chemother 2007;60:107-11.
78. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27:175-81.
79. Schnyder B, Pichler WJ. Skin and laboratory tests in amoxicillin- and penicillin-induced morbilliform skin eruption. Clin Exp Allergy 2000;30:590-5.
80. Luque I, Leyva L, Torres MJ, Rosal M, Mayorga C, Segura JM, Blanca M, Juárez C. In vitro T-cell responses to b-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001;56:611-8.
81. Mayorga C, R. Pena R, Blanca-López N, López S, Martín E, Torres MJ. Monitoring the acute phase response in non-immediate allergic drug reactions. Curr Opin Allergy Clin Immunol 2006;6:249-57.